CA2360085A1 - Genes identified as required for proliferation in escherichia coli - Google Patents

Genes identified as required for proliferation in escherichia coli Download PDF

Info

Publication number
CA2360085A1
CA2360085A1 CA002360085A CA2360085A CA2360085A1 CA 2360085 A1 CA2360085 A1 CA 2360085A1 CA 002360085 A CA002360085 A CA 002360085A CA 2360085 A CA2360085 A CA 2360085A CA 2360085 A1 CA2360085 A1 CA 2360085A1
Authority
CA
Canada
Prior art keywords
nucleic acid
cell
proliferation
seq
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002360085A
Other languages
English (en)
French (fr)
Inventor
Judith Zyskind
Kari L. Ohlsen
John D. Trawick
R. Allyn Forsyth
Jamie M. Froelich
Grant J. Carr
Robert T. Yamamoto
H. Howard Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Elitra Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2360085A1 publication Critical patent/CA2360085A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Wood Science & Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
CA002360085A 1999-01-27 2000-01-27 Genes identified as required for proliferation in escherichia coli Abandoned CA2360085A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US11740599P 1999-01-27 1999-01-27
US60/117,405 1999-01-27
PCT/US2000/002200 WO2000044906A2 (en) 1999-01-27 2000-01-27 GENES IDENTIFIED AS REQUIRED FOR PROLIFERATION IN $i(ESCHERICHIA COLI)

Publications (1)

Publication Number Publication Date
CA2360085A1 true CA2360085A1 (en) 2000-08-03

Family

ID=22372748

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002360085A Abandoned CA2360085A1 (en) 1999-01-27 2000-01-27 Genes identified as required for proliferation in escherichia coli

Country Status (7)

Country Link
EP (1) EP1149166A2 (xx)
JP (1) JP2002535007A (xx)
KR (1) KR20010101861A (xx)
AU (1) AU3584500A (xx)
CA (1) CA2360085A1 (xx)
NZ (1) NZ512835A (xx)
WO (1) WO2000044906A2 (xx)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1130094A3 (en) * 1999-07-08 2001-11-21 Helix Research Institute Primers for synthesizing full length cDNA clones and their use
EP1220903A1 (en) * 1999-10-13 2002-07-10 Pantheco A/S Gene selection using pnas
US6783985B1 (en) 2000-02-18 2004-08-31 Elitra Pharmaceuticals Inc. Gene disruption methodologies for drug target discovery
WO2002079467A2 (en) * 2001-03-29 2002-10-10 Københavns Universitet Antibiotic-free bacterial strain selection with antisense molecules
US20030082591A1 (en) * 2001-07-24 2003-05-01 Donald Awrey Methods for gene disruption and uses thereof
FR2842210B1 (fr) * 2002-07-09 2012-12-14 Mutabilis Determinants de pathogenicite utilisables comme cibles pour l'elaboration de moyens de prevention et de controle d'infections bacteriennes et/ou de la dissemination systemique
US20090209623A1 (en) * 2005-07-25 2009-08-20 Jon Tomono Anti-sense nucleic acid derived from organism
CA2620577A1 (en) * 2005-09-01 2007-03-08 The Feinstein Institute For Medical Research Peptide mimics of melanocyte stimulating hormone
US20120301434A1 (en) * 2009-10-02 2012-11-29 Oslo Universitetssykehus Hf Antibacterial polypeptides and use thereof
US9090928B2 (en) * 2010-10-07 2015-07-28 Yale University Site-specific incorporation of phosphoserine into proteins in Escherichia coli
US9464288B2 (en) 2011-07-11 2016-10-11 Yale University Compositions and methods for making selenocysteine containing polypeptides
US11788111B2 (en) 2011-07-11 2023-10-17 Yale University Compositions and methods for making selenocysteine containing polypeptides
US10240158B2 (en) 2011-07-11 2019-03-26 Yale University Compositions and methods for making selenocysteine containing polypeptides
US10876142B2 (en) 2011-07-11 2020-12-29 Yale University Compositions and methods for making selenocysteine containing polypeptides
CA3127177A1 (en) * 2019-01-31 2020-08-06 Spiber Inc. Method for producing recombinant protein
CN113917140B (zh) * 2021-10-28 2023-08-18 生工生物工程（上海）股份有限公司 一种快速筛选原核蛋白表达菌的方法
CN116218890A (zh) * 2021-12-06 2023-06-06 深圳华大生命科学研究院 基因串联表达盒、多位点基因编辑系统及应用
US11866728B2 (en) 2022-01-21 2024-01-09 Renagade Therapeutics Management Inc. Engineered retrons and methods of use

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0960212B1 (en) * 1996-11-13 2007-05-09 Qbi Enterprises Ltd. Gene identification method
US6610539B1 (en) * 1997-07-10 2003-08-26 Genesense Technologies, Inc. Antisense oligonucleotide sequences as inhibitors of microorganisms

Also Published As

Publication number Publication date
JP2002535007A (ja) 2002-10-22
EP1149166A2 (en) 2001-10-31
WO2000044906A2 (en) 2000-08-03
NZ512835A (en) 2004-02-27
WO2000044906A3 (en) 2001-02-01
AU3584500A (en) 2000-08-18
KR20010101861A (ko) 2001-11-15

Similar Documents

Publication Publication Date Title
US20040029129A1 (en) Identification of essential genes in microorganisms
US20020061569A1 (en) Identification of essential genes in prokaryotes
US6720139B1 (en) Genes identified as required for proliferation in Escherichia coli
WO2002077183A2 (en) Identification of essential genes in microorganisms
CA2360085A1 (en) Genes identified as required for proliferation in escherichia coli
WO2001048209A2 (en) Genes identified as required for proliferation of e. coli
Braun et al. Ton-dependent colicins and microcins: modular design and evolution
Bolhuis et al. The lactococcal lmrP gene encodes a proton motive force-dependent drug transporter
JP2008154584A (ja) 抗菌方法と材料
US6589738B1 (en) Genes essential for microbial proliferation and antisense thereto
JP2012517801A (ja) 非リボソームペプチドシンターゼをコードする生合成クラスターの核酸分子およびその使用
US20080131465A1 (en) Group a Streptococcus Crge Protein
EP1178052A2 (en) Genes identified as required for proliferation in Escherichia coli
US20030170694A1 (en) Stabilized nucleic acids in gene and drug discovery and methods of use
US6764823B2 (en) Antimicrobial methods and materials
US20050026189A1 (en) Microbial operons
EA007413B1 (ru) Полипептид для оживления покоящихся, погибающих или латентных бактериальных клеток, кодирующая его нуклеиновая кислота и способы использования полипептида и нуклеиновой кислоты
CA2365929A1 (en) Novel method for identifying antibacterial compounds
US7390620B2 (en) Screening method for anti-microbial drug targets by genome-saturating mutagenesis (GSM)
Dougherty et al. 98th General Meeting of the American Society for Microbiology
Jo Two novel outer membrane proteins involved in intrinsic aminoglycoside resistence in Pseudomonas aeruginosa
Kuinkel The role of the Staphylococcus aureus LytSR two-component regulatory system in cell death and lysis

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead